0.00Open141.40Pre Close0 Volume0 Open Interest440.00Strike Price0.00Turnover5151.84%IV-2.91%PremiumNov 22, 2024Expiry Date158.83Intrinsic Value100Multiplier-4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9982Delta0.0001Gamma4.24Leverage Ratio-100.0455Theta0.0000Rho4.23Eff Leverage0.0001Vega
SPDR S&P 500 ETF Stock Discussion
1. Innovative Pipeline: TPST is a clinical-stage biotechnology company focused on developing small molecule therapeutics for cancer treatment. Their leading programs, TPST-1495 and TPST-1120, are in Phase 1 trials targeting various tumors.
2. Strategic Partnerships: The company has a collaboration with Roche to advance TPST-1120 in combination with other therapies...
I got kicked out in stop loss...and was thrown bread crumbs.. you couldn't give ya boi at least 3 slices?!..Happy Thanksgiving to you too..[Sweats] 🦃
No comment yet